Clinical trials recruiting for Unresectable Breast Cancer
3
Recruiting trials
1
US states with sites
11
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CDK4/6 + Endocrine therapy | 1 |
| Trastuzumab (Herceptin) | 1 |
| Trastuzumab deruxtecan | 1 |
| Tucatinib (ONT-380) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Missouri | 1 |
Top cities
Self-screener
Recruiting trials
- BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
- DESTINY Breast Respond HER2-(Ultra)Low Europe
- Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
Related conditions
Trials recruiting for Unresectable Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Unresectable Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.